Legal Opinion

Board of Regents, The University of Texas System v. Boston Scientific Corporation

District Court, D. Delaware

Decided December 2, 2022No. 1:18-cv-00392Unknown

1Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM and TISSUEGEN, Inc. Plaintiffs, Civil Action No. 18-392-GBW v. BOSTON SCIENTIFIC Corp. Defendant. MEMORANDUM ORDER Plaintiffs TissueGen, Inc.’s and the Board of Regents, The University of Texas System’s (collectively, “UT”) First Amended Complaint alleges that Defendant Boston Scientific Corp. (“BSC”) directly, indirectly, and willfully infringed, via its “Synergy” brand coronary stents (the “Accused Products”), claims 1, 11, 12, 17, and 26 (the “Asserted Claims”) of

U.S. Patent…

2Cases cited4 opinions

  1. Thabault v. Chait Ex Rel. Estate of ChaitCourt of Appeals for the Third Circuit · 2008
  2. Nick Idzojtic, in No. 71-1019, and John Skocich v. The Pennsylvania Railroad Company, a Corporation v. Edward Kozora. Appeal of John Skocich, in No. 71-1020Court of Appeals for the Third Circuit · 1972
  3. Senorx, Inc. v. Hologic, Inc.District Court, D. Delaware · 2013
  4. Laboratory Skin Care, Inc. v. Limited Brands, Inc.District Court, D. Delaware · 2010

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API